Last update 12 Jul 2024

Zipalertinib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CLN 081, CLN-081, TAS-6417
+ [1]
Mechanism
EGFR exon 20 inhibitors(EGFR exon 20 Mutation inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
RegulationBreakthrough Therapy (US)

Structure

Molecular FormulaC23H20N6O
InChIKeyMKCYPWYURWOKST-INIZCTEOSA-N
CAS Registry1661854-97-2

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
EGFR-mutated non-small Cell Lung CancerPhase 3
US
30 Jun 2023
EGFR-mutated non-small Cell Lung CancerPhase 3
JP
30 Jun 2023
EGFR-mutated non-small Cell Lung CancerPhase 3
BE
30 Jun 2023
EGFR-mutated non-small Cell Lung CancerPhase 3
CA
30 Jun 2023
EGFR-mutated non-small Cell Lung CancerPhase 3
FR
30 Jun 2023
EGFR-mutated non-small Cell Lung CancerPhase 3
DE
30 Jun 2023
EGFR-mutated non-small Cell Lung CancerPhase 3
IL
30 Jun 2023
EGFR-mutated non-small Cell Lung CancerPhase 3
IT
30 Jun 2023
EGFR-mutated non-small Cell Lung CancerPhase 3
NL
30 Jun 2023
EGFR-mutated non-small Cell Lung CancerPhase 3
PH
30 Jun 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
73
ufkorxneyn(kxtddjanlr) = cbcsncbebf djlbmsqiiw (rqiipdirjq )
-
29 Jun 2023
Phase 1/2
Non-Small Cell Lung Cancer
EGFR Exon 20 Insertion
73
cwndiqmrbt(ysohlkwcms) = giymhjnsbu nfvqnysmty (inwbzpdrsh )
Positive
02 Jun 2022
Phase 1/2
37
qdxidxelph(uvxltpaiac) = gzjptzlwgz noysoyknaa (ariashsqlr )
Positive
20 May 2021
Phase 1/2
9
scmbczrvhr(fdeohvyowb) = 8% qhxmhthayn (rrwtgnhqjp )
Positive
17 Sep 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free